Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Flu Vaccine Only About 50% Effective This Year: CDC February 21, 2017 Martha Garcia Add Your Comments Recent testing by government health officials suggests that this year’s flu vaccine may only be effective in about half of the population, suggesting that many are at risk as the flu sweeps across the U.S. and the number of illnesses continues to increase. Researchers at the U.S. Centers for Disease Control and Prevention (CDC) indicate that while this year’s flu vaccine is not as good as last year’s formula, it is better than prior years. The agency’s findings and new flu vaccine recommendations are outlined in the latest edition of the CDC Morbidity and Mortality Weekly Report, concluding that this year’s influenza vaccination lowers an individual’s risk of requiring hospitalization or treatment at the ER by 48%. However, it appears to only be about 50% effective. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION There are about half a dozen different flu vaccines, formulated differently to protect against various strains of the flu. Taken together they provide 43% protection against this year’s most common viruses, including H3N2. They offer 73% effectiveness against influenza B. The report comes following a recent CDC warning against using FluMist, a live attenuated influenza vaccine administered nasally. The CDC warned that the product lacked effectiveness, with only a three percent effectiveness among children. New research also indicates FluMist may not protect against several strains of the virus that have been prominent over the last three flu seasons. Flu viruses mutate constantly and can change from one month to the next, or from one country to the next. This is why new flu vaccine formulations are needed each year. The vaccine protects against the virus for only a few months after it has been administered. Researchers indicate the flu vaccine was moderately less effective in Europe this year, protecting about 38% of people from infection. It was the least effective among the sick and elderly. During an average year, the flu kills up to 50,000 people, mostly weak and elderly people. About a quarter-million people will require hospitalization. The 2016-2017 formulation of the vaccine reduced the risk of illness associated medical visits by about half. The flu has killed 20 children in the U.S. this season. Pediatric deaths have ranged from 37 to 171 each year since 2004, since influenza-associated pediatric deaths became a national notifiable condition. That data does not include the 2009-2010 flu season, the year the swine flu infected the population. H1N1 was a brand new strain that year, killing 358 children that season. The agency said flu activity is likely to continue for several more weeks and vaccination efforts should continue as long as viruses are circulating. This season in the U.S. is considered moderate. It has not been particularly deadly and has not infected more people than usual during annual flu season. Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Child Death, Childrens Drug, Flu, Flu Drug, FluMist, Swine Flu More Lawsuit Stories Bard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 January 15, 2026 Abbott FreeStyle Libre Lawsuit Alleges Recalled Glucose Monitor Led to Inaccurate Readings January 15, 2026 $79 Billion in Class Action Settlements Paid by Corporations in 2025: Report January 15, 2026 0 Comments NameThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Bard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 (Posted: today) A federal judge has scheduled a series of Bard PowerPort trials between April 2026 and February 2027, which will focus on allegations that defective design flaws made the devices susceptible to infections, fractures and migration. MORE ABOUT: BARD POWERPORT LAWSUITCook Flexor Sheath Lawsuit Claims Defective Catheter Device Led to Woman’s Death (01/06/2026)More Than 2,500 Bard Powerport Lawsuits Filed in Federal Courts Nationwide (12/05/2025)Six Bard PowerPort Lawsuits Will Go Before Juries Between May 2026 and Feb. 2027 (11/26/2025) Depo-Provera Lawyers Intending To Remain in MDL Leadership Must Seek Reappointment: Judge (Posted: yesterday) A federal judge is calling for dozens of attorneys to reapply for leadership positions in Depo-Provera brain tumor litigation before their appointments expire in March. MORE ABOUT: DEPO-PROVERA LAWSUITSide Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (01/06/2026)Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025) Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference (Posted: 2 days ago) Parties involved with Ozempic blindness lawsuits will meet with a federal judge overseeing the litigation for the first time on January 13. MORE ABOUT: OZEMPIC LAWSUITFDA To Remove Suicide Risks From GLP-1 Side Effects Warnings (01/15/2026)Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 (12/23/2025)Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (12/18/2025)
Abbott FreeStyle Libre Lawsuit Alleges Recalled Glucose Monitor Led to Inaccurate Readings January 15, 2026
Bard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 (Posted: today) A federal judge has scheduled a series of Bard PowerPort trials between April 2026 and February 2027, which will focus on allegations that defective design flaws made the devices susceptible to infections, fractures and migration. MORE ABOUT: BARD POWERPORT LAWSUITCook Flexor Sheath Lawsuit Claims Defective Catheter Device Led to Woman’s Death (01/06/2026)More Than 2,500 Bard Powerport Lawsuits Filed in Federal Courts Nationwide (12/05/2025)Six Bard PowerPort Lawsuits Will Go Before Juries Between May 2026 and Feb. 2027 (11/26/2025)
Depo-Provera Lawyers Intending To Remain in MDL Leadership Must Seek Reappointment: Judge (Posted: yesterday) A federal judge is calling for dozens of attorneys to reapply for leadership positions in Depo-Provera brain tumor litigation before their appointments expire in March. MORE ABOUT: DEPO-PROVERA LAWSUITSide Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (01/06/2026)Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)
Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference (Posted: 2 days ago) Parties involved with Ozempic blindness lawsuits will meet with a federal judge overseeing the litigation for the first time on January 13. MORE ABOUT: OZEMPIC LAWSUITFDA To Remove Suicide Risks From GLP-1 Side Effects Warnings (01/15/2026)Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 (12/23/2025)Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (12/18/2025)